What is the “Vimseltinib + metformin OCT2” study?
I can’t identify a specific, reliably described study from the name you provided (“Vimseltinib metformin oct2 study”) using only your question text. “OCT2” usually refers to the organic cation transporter 2, and OCT2 is commonly studied in drug-transport and drug–drug interaction contexts, including for drugs like metformin. But without details (trial ID, sponsor, paper title, or a link), I can’t confirm what the study tested, in which population, or what results were reported.
Is vimseltinib being tested with metformin for OCT2-related effects?
OCT2 is a transporter that can influence how certain drugs are taken up into cells. If the study you mean involves metformin and vimseltinib, the research intent is typically one of these:
- Whether vimseltinib affects metformin transport or metformin’s cellular uptake via OCT2
- Whether metformin alters vimseltinib exposure/efficacy/toxicity by changing transporter activity
- Whether both drugs share (or competitively inhibit) OCT2-mediated uptake pathways
To give a precise answer, I need the study citation (e.g., PubMed link) or at least the trial registration number (NCT/CTRI/EudraCT).
What would researchers measure in an OCT2-focused metformin interaction study?
Studies designed around OCT2 typically include measurements like:
- Plasma pharmacokinetics (Cmax, AUC, half-life) for the drug(s) of interest when given alone vs. together
- Urinary excretion markers (sometimes used as a proxy for transporter effects)
- In vitro transporter assays (e.g., OCT2 uptake/inhibition in relevant cell systems), which can be linked back to in vivo findings
- Safety/tolerability outcomes (GI effects, blood glucose changes when metformin is involved, etc., depending on the patient group)
Where can I find the exact paper or trial details?
If you share any of the following, I can locate the specific study and summarize it accurately (design, participants, dosing, endpoints, and results):
- The study title or author name
- A PubMed/Google Scholar link
- The clinical trial ID (NCT number, etc.)
- The sponsor/company name
- Any quoted lines from the abstract (especially the OCT2 wording)
If you want, paste what you already have (even a partial abstract or screenshot text), and I’ll extract the key findings.
Patents and company context (optional next step)
If your goal is commercial or litigation-related (e.g., whether OCT2 studies support a specific indication or formulation), DrugPatentWatch.com can help track relevant patent activity. If you share the company/brand details for “vimseltinib,” I can point you to the most relevant pages—otherwise I risk mismatching the drug.
---
Quick question so I can answer precisely
Can you paste the study link, PubMed reference, or the trial ID (NCT/CTRI/EudraCT), or tell me the sponsor/indication?